grepcent public filings, reorganized for comparison

Analysis reports

Highest return on assets

Companies ranked mechanically by latest return on assets from SEC companyfacts.

Descriptive ranking — not investment advice. Mechanical ranking by stated metric from SEC/FRED data; not a recommendation, endorsement, or investment judgment. As of: 2026-09-18. See Disclaimer.

Chart

Highest return on assets. Source: grepcent computed analysis from site-data.json.Highest return on assets. Source: grepcent computed analysis from site-data.json.Highest return on assetsHighest displayed value: WINA = 167.39%Source: grepcent computed analysis from site-data.json.Latest ROA (%)Latest ROA0.0%87.5%175.0%WINAAISPSEATARENRIGLWDCCHRSVRSNNVDABCRXSNDKAPPUISITCTGTXDAVEAUPHNVAXNATHBYNDDPZFICOSEZLABEOSTXSNWVIDXXLYFTAAPLLRCXEVERNTNXTPLZVRABYDDECKMAEXELKLACPSIXMANHKROSNVECWINGBTMDACADFASTVISNSPIRADBE

Table

RankCompanyLatest ROAFYPeriod endComparabilityRegimeExtra
1WINA - WINMARK CORP167.39%2025as of 2025-12-27-4d (aligned)operating
2AISP - Airship AI Holdings, Inc.150.56%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (29,321,363 USD) exceeded revenue (15,321,349 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
3SEAT - Vivid Seats Inc.126.57%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (806,054,000 USD) exceeded revenue (450,509,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
4AREN - Arena Group Holdings, Inc.110.88%2025as of 2025-12-310d (aligned)operating
5RIGL - RIGEL PHARMACEUTICALS INC71.46%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (367,024,000 USD) exceeded revenue (294,282,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
6WDC - WESTERN DIGITAL CORP67.99%2026as of 2026-07-03about 6 months after row reference (+184d) (offset)operating
7CHRS - Coherus Oncology, Inc.65.04%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (168,024,000 USD) exceeded revenue (42,172,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
8VRSN - VERISIGN INC/CA62.27%2025as of 2025-12-310d (aligned)operating
9NVDA - NVIDIA CORP58.06%2026as of 2026-01-25+25d (offset)operating
10BCRX - BIOCRYST PHARMACEUTICALS INC51.32%2025as of 2025-12-310d (aligned)operating
11SNDK - Sandisk Corp50.80%2026as of 2026-07-03about 6 months after row reference (+184d) (offset)operating
12APP - AppLovin Corp45.92%2025as of 2025-12-310d (aligned)operating
13UI - Ubiquiti Inc.43.69%2026as of 2026-06-30about 6 months after row reference (+181d) (offset)operating
14SITC - SITE Centers Corp.42.48%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (177,861,000 USD) exceeded revenue (123,649,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
financial
15TGTX - TG THERAPEUTICS, INC.42.06%2025as of 2025-12-310d (aligned)operating
16DAVE - Dave Inc./DE40.18%2025as of 2025-12-310d (aligned)financial
17AUPH - Aurinia Pharmaceuticals Inc.38.21%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (287,202,000 USD) exceeded revenue (283,055,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
18NVAX - NOVAVAX INC37.42%2025as of 2025-12-310d (aligned)operating
19NATH - NATHANS FAMOUS, INC.37.32%2026as of 2026-03-29about 3 months after row reference (+88d) (offset)operating
20BYND - BEYOND MEAT, INC.35.63%2025as of 2025-12-310d (aligned)operating
21DPZ - DOMINOS PIZZA INC35.05%2025as of 2025-12-28-3d (aligned)operating
22FICO - FAIR ISAAC CORP34.90%2025as of 2025-09-30about 3 months before row reference (-92d) (offset)operating
23SEZL - Sezzle Inc.33.26%2025as of 2025-12-310d (aligned)operating
24ABEO - ABEONA THERAPEUTICS INC.32.42%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (71,183,000 USD) exceeded revenue (5,820,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
25STX - Seagate Technology Holdings plc31.93%2026as of 2026-07-03about 6 months after row reference (+184d) (offset)operating
26SNWV - SANUWAVE Health, Inc.31.63%2025as of 2025-12-310d (aligned)operating
27IDXX - IDEXX LABORATORIES INC /DE31.62%2025as of 2025-12-310d (aligned)operating
28LYFT - Lyft, Inc.31.49%2025as of 2025-12-310d (aligned)operating
29AAPL - Apple Inc.31.18%2025as of 2025-09-27about 3 months before row reference (-95d) (offset)operating
30LRCX - LAM RESEARCH CORP30.88%2026as of 2026-06-28about 6 months after row reference (+179d) (offset)operating
31EVER - EverQuote, Inc.30.38%2025as of 2025-12-310d (aligned)operating
32NTNX - Nutanix, Inc.29.70%2026as of 2026-07-31about 7 months after row reference (+212d) (offset)operating
33TPL - Texas Pacific Land Corp29.65%2025as of 2025-12-310d (aligned)financial
34ZVRA - ZEVRA THERAPEUTICS, INC.29.23%2025as of 2025-12-310d (aligned)operating
35BYD - BOYD GAMING CORP28.04%2025as of 2025-12-310d (aligned)operating
36DECK - DECKERS OUTDOOR CORP27.77%2026as of 2026-03-31about 3 months after row reference (+90d) (offset)operating
37MA - Mastercard Inc27.64%2025as of 2025-12-310d (aligned)operating
38EXEL - EXELIXIS, INC.27.51%2025as of 2026-01-02+2d (aligned)operating
39KLAC - KLA CORP26.91%2026as of 2026-06-30about 6 months after row reference (+181d) (offset)operating
40PSIX - POWER SOLUTIONS INTERNATIONAL, INC.26.84%2025as of 2025-12-310d (aligned)operating
41MANH - MANHATTAN ASSOCIATES INC26.20%2025as of 2025-12-310d (aligned)operating
42KROS - Keros Therapeutics, Inc.25.74%2025as of 2025-12-310d (aligned)operating
43NVEC - NVE CORP /NEW/25.17%2026as of 2026-03-31about 3 months after row reference (+90d) (offset)operating
44WING - Wingstop Inc.25.13%2025as of 2025-12-27-4d (aligned)operating
45BTMD - biote Corp.25.13%2025as of 2025-12-310d (aligned)operating
46ACAD - ACADIA PHARMACEUTICALS INC25.00%2025as of 2025-12-310d (aligned)operating
47FAST - FASTENAL CO24.90%2025as of 2025-12-310d (aligned)operating
48VISN - Vistance Networks, Inc.24.37%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (2,283,700,000 USD) exceeded revenue (1,931,600,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operating
49SPIR - Spire Global, Inc.24.32%2025as of 2025-12-310d (aligned)operating
50ADBE - ADOBE INC.24.17%2025as of 2025-11-28-33d (offset)operating